Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

South Korea flag South Korea · Delayed Price · Currency is KRW
825,000
+68,000 (8.98%)
Feb 27, 2026, 3:30 PM KST
333.30%
Market Cap 19.19T
Revenue (ttm) 220.74B
Net Income (ttm) -11.40B
Shares Out 23.26M
EPS (ttm) -490.31
PE Ratio n/a
Forward PE n/a
Dividend 200.00 (0.02%)
Ex-Dividend Date Dec 29, 2025
Volume 513,529
Average Volume 337,462
Open 857,000
Previous Close 757,000
Day's Range 799,000 - 860,000
52-Week Range 127,600 - 860,000
Beta 2.29
RSI 81.89
Earnings Date Mar 18, 2026

About Sam Chun Dang Pharm.

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, S... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1943
Employees 422
Stock Exchange KOSDAQ
Ticker Symbol 000250
Full Company Profile

Financial Performance

In 2024, Sam Chun Dang Pharm.'s revenue was 210.92 billion, an increase of 9.47% compared to the previous year's 192.67 billion. Losses were -10.92 billion, 5.14% more than in 2023.

Financial Statements

News

There is no news available yet.